Share Name Share Symbol Market Type Share ISIN Share Description
Abzena LSE:ABZA London Ordinary Share GB00BN65QN46 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -1.10% 45.00p 44.00p 46.00p 45.50p 44.50p - 68,969 08:56:32
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18.7 -9.5 -7.0 - 62.03

Abzena (ABZA) Latest News

More Abzena News
Abzena Takeover Rumours

Abzena (ABZA) Share Charts

1 Year Abzena Chart

1 Year Abzena Chart

1 Month Abzena Chart

1 Month Abzena Chart

Intraday Abzena Chart

Intraday Abzena Chart

Abzena (ABZA) Discussions and Chat

Abzena Forums and Chat

Date Time Title Posts
22/6/201719:40Abzena PLC -development of biopharmaceutical products138

Add a New Thread

Abzena (ABZA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
08:07:2844.315,0002,215.50O
07:56:5744.257,4693,305.03O
07:23:2645.004,5002,025.00O
07:23:1345.0018,0008,100.00O
07:17:1945.006,0002,700.00O
View all Abzena trades in real-time

Abzena (ABZA) Top Chat Posts

DateSubject
23/6/2017
09:20
Abzena Daily Update: Abzena is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ABZA. The last closing price for Abzena was 45.50p.
Abzena has a 4 week average price of 37.50p and a 12 week average price of 31.25p.
The 1 year high share price is 64p while the 1 year low share price is currently 31.25p.
There are currently 137,846,327 shares in issue and the average daily traded volume is 22,556 shares. The market capitalisation of Abzena is £62,720,078.79.
12/6/2017
10:03
qs99: nope, but brokers seem upbeat and share price has chugged along nicely, so fingers Xd!
23/1/2017
22:03
qs99: well N+1 Singer who IMO are a decent outfit have a 93p intrinsic value DYOR and talk of further upside or as they put it the value would "increase substantially" as the partnered pipeline of Abzena inside programmes progress through clinical trial.....and from what I can see they are not expecting any cash call in the near term....DYOR as I say but just because My RF doesn't like this, does not mean he is correct....of course there are risks, as the RNS before Xmas showed when one of the programmes didn't progress, but that is the whole point of continuing to fill the "hopper" IMO so that on a portfolio basis they should IMO have more successes or at least enough that provides material upside to the current share price. GLA
20/1/2017
07:41
22richyrich: On initial read of rns sounds positive $300million potential income..but then looked at share price last 12 months and fact this deal at lower value was announced 10 months ago and realised it's a classic loss making aim jam tomorrow story
10/7/2014
08:56
43rick: ipo share price 80p hxxp://www.abzena.com/company Woodford investment management hold 10.2% hxxp://www.abzena.com/share-information hxxp://www.abzena.com/news/130/83/Abzena-raises-20-million-in-connection-with-forthcoming-admission-to-AIM.html hxxp://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10902920/Abzena-defies-stock-market-jitters-to-announce-float-plans.html
Abzena share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170623 08:35:42